These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3871761)

  • 1. Conversion of cloxacillin into a progressive inhibitor of beta-lactamases by sulfonation and its activity against various types of these enzymes.
    Yamaguchi A; Adachi A; Hirata T; Adachi H; Sawai T
    J Antibiot (Tokyo); 1985 Jan; 38(1):83-93. PubMed ID: 3871761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed inactivation of Citrobacter freundii cephalosporinase by 6 beta-[3-(2-chlorophenyl)-5-methyl-4-isoxazolyl]penicillin sulfone.
    Yamaguchi A; Nemoto M; Adachi A; Inaba T; Sawai T
    J Antibiot (Tokyo); 1986 Dec; 39(12):1744-53. PubMed ID: 3493233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid sequence, active-site residue, and effect of suicide inhibitors on cephalosporinase of Citrobacter freundii GN346.
    Sawai T; Yamaguchi A; Tsukamoto K
    Rev Infect Dis; 1988; 10(4):721-5. PubMed ID: 3263684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefoxitin, N-formimidoyl thienamycin, clavulanic acid, and penicillanic acid sulfone as suicide inhibitors for different types of beta-lactamases produced by gram-negative bacteria.
    Sawai T; Tsukamoto K
    J Antibiot (Tokyo); 1982 Nov; 35(11):1594-602. PubMed ID: 6298169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of beta-lactamase inhibition: differences between sulbactam and other inhibitors.
    Sawai T; Yamaguchi A
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):121S-129S. PubMed ID: 2591172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of aztreonam as a substrate, inhibitor and inducer for beta-lactamases.
    Sakurai Y; Yoshida Y; Saitoh K; Nemoto M; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1990 Apr; 43(4):403-10. PubMed ID: 2112533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.
    Yamaguchi A; Hirata T; Sawai T
    Antimicrob Agents Chemother; 1984 Mar; 25(3):348-53. PubMed ID: 6372682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis and evaluation of 6-alkylidene-2'beta-substituted penam sulfones as beta-lactamase inhibitors.
    Buynak JD; Rao AS; Doppalapudi VR; Adam G; Petersen PJ; Nidamarthy SD
    Bioorg Med Chem Lett; 1999 Jul; 9(14):1997-2002. PubMed ID: 10450969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam.
    Yamaguchi A; Hirata T; Sawai T
    Antimicrob Agents Chemother; 1983 Jul; 24(1):23-30. PubMed ID: 6312873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method for testing the efficacy of a beta-lactamase inhibitor against beta-lactamase-producing gram-negative bacteria.
    Sawai T; Yoshida T
    J Antibiot (Tokyo); 1982 Aug; 35(8):1072-7. PubMed ID: 6982888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-(1-Hydroxyalkyl))penam sulfone derivatives as inhibitors of class A and class C beta-lactamases II.
    Bitha P; Li Z; Francisco GD; Yang Y; Petersen PJ; Lenoy E; Lin YI
    Bioorg Med Chem Lett; 1999 Apr; 9(7):997-1002. PubMed ID: 10230627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-lactamases from Yersinia enterocolitica.
    Cornelis G; Abraham EP
    J Gen Microbiol; 1975 Apr; 87(2):273-84. PubMed ID: 237976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and evaluation of 2 beta-alkenyl penam sulfone acids as inhibitors of beta-lactamases.
    Richter HG; Angehrn P; Hubschwerlen C; Kania M; Page MG; Specklin JL; Winkler FK
    J Med Chem; 1996 Sep; 39(19):3712-22. PubMed ID: 8809160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-directed mutagenesis and substrate-induced inactivation of beta-lactamase I.
    Thornewell SJ; Waley SG
    Biochem J; 1992 Dec; 288 ( Pt 3)(Pt 3):1045-51. PubMed ID: 1471977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of a cephalosporinase inhibitor derived from cloxacillin sulfone in the presence of phosphate anions.
    Yamaguchi A; Inaba T; Sawai T
    J Antibiot (Tokyo); 1988 May; 41(5):690-3. PubMed ID: 3260231
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification and properties of a constitutive beta-lactamase from Pseudomonas aeruginosa strain Dalgleish.
    Furth AJ
    Biochim Biophys Acta; 1975 Feb; 377(2):431-43. PubMed ID: 235307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of penam sulfones as inhibitors of beta-lactamases.
    Phillips OA; Reddy AV; Setti EL; Spevak P; Czajkowski DP; Atwal H; Salama S; Micetich RG; Maiti SN
    Bioorg Med Chem; 2005 Apr; 13(8):2847-58. PubMed ID: 15781395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 6-(1-Hydroxyalkyl)penam sulfone derivatives as inhibitors of class A and class C beta-lactamases I.
    Bitha P; Li Z; Francisco GD; Rasmussen BA; Lin YI
    Bioorg Med Chem Lett; 1999 Apr; 9(7):991-6. PubMed ID: 10230626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.
    Padayatti PS; Sheri A; Totir MA; Helfand MS; Carey MP; Anderson VE; Carey PR; Bethel CR; Bonomo RA; Buynak JD; van den Akker F
    J Am Chem Soc; 2006 Oct; 128(40):13235-42. PubMed ID: 17017804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of the RTEM beta-lactamase from Escherichia coli. Interaction of penam sulfones with enzyme.
    Fisher J; Charnas RL; Bradley SM; Knowles JR
    Biochemistry; 1981 May; 20(10):2726-31. PubMed ID: 7018564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.